{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/TNXP/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-14T23:55:15.087Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":2891,"canonical_name":"Tonix Pharmaceuticals Holding Corp.","cik":"0001430306","uei":null,"lei":null,"duns":null,"ticker":"TNXP"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":29},"count":29,"timeline":[{"ts":"2026-10-02","kind":"sec.filing","form_type":"8-K","title":"8-K — Tonix Pharmaceuticals Holding Corp. — 2026-10-02","url_slug":"/sec/cik-0001430306/8-k/0001493152-26-045603","accession_number":"0001493152-26-045603","importance":35},{"ts":"2026-09-22","kind":"sec.filing","form_type":"8-K","title":"8-K — Tonix Pharmaceuticals Holding Corp. — 2026-09-22","url_slug":"/sec/cik-0001430306/8-k/0001493152-26-043644","accession_number":"0001493152-26-043644","importance":35},{"ts":"2026-09-08","kind":"sec.filing","form_type":"8-K","title":"8-K — Tonix Pharmaceuticals Holding Corp. — 2026-09-08","url_slug":"/sec/cik-0001430306/8-k/0001493152-26-041689","accession_number":"0001493152-26-041689","importance":35},{"ts":"2026-09-08","kind":"sec.filing","form_type":"3","title":"3 — Tonix Pharmaceuticals Holding Corp. — 2026-09-08","url_slug":"/sec/cik-0001430306/3/0001493152-26-041688","accession_number":"0001493152-26-041688","importance":30},{"ts":"2026-08-31","kind":"sec.filing","form_type":"4","title":"4 — Tonix Pharmaceuticals Holding Corp. — 2026-08-31","url_slug":"/sec/cik-0001430306/4/0001493152-26-040736","accession_number":"0001493152-26-040736","importance":30},{"ts":"2026-08-18","kind":"sec.filing","form_type":"8-K","title":"8-K — Tonix Pharmaceuticals Holding Corp. — 2026-08-18","url_slug":"/sec/cik-0001430306/8-k/0001493152-26-039000","accession_number":"0001493152-26-039000","importance":35},{"ts":"2026-08-14","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Tonix Pharmaceuticals Holding Corp. — 2026-08-14","url_slug":"/sec/cik-0001430306/schedule-13g-a/0000919574-26-005208","accession_number":"0000919574-26-005208","importance":30},{"ts":"2026-08-10","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Tonix Pharmaceuticals Holding Corp. — 2026-08-10","url_slug":"/sec/cik-0001430306/10-q/0001999371-26-017452","accession_number":"0001999371-26-017452","importance":45},{"ts":"2026-08-10","kind":"sec.filing","form_type":"8-K","title":"8-K — Tonix Pharmaceuticals Holding Corp. — 2026-08-10","url_slug":"/sec/cik-0001430306/8-k/0001493152-26-036740","accession_number":"0001493152-26-036740","importance":35},{"ts":"2026-08-03","kind":"sec.filing","form_type":"8-K","title":"8-K — Tonix Pharmaceuticals Holding Corp. — 2026-08-03","url_slug":"/sec/cik-0001430306/8-k/0001493152-26-035741","accession_number":"0001493152-26-035741","importance":35},{"ts":"2026-07-21","kind":"sec.filing","form_type":"8-K","title":"8-K — Tonix Pharmaceuticals Holding Corp. — 2026-07-21","url_slug":"/sec/cik-0001430306/8-k/0001493152-26-034079","accession_number":"0001493152-26-034079","importance":35},{"ts":"2026-07-13","kind":"sec.filing","form_type":"8-K","title":"8-K — Tonix Pharmaceuticals Holding Corp. — 2026-07-13","url_slug":"/sec/cik-0001430306/8-k/0001493152-26-032925","accession_number":"0001493152-26-032925","importance":35},{"ts":"2026-07-01","kind":"sec.filing","form_type":"S-8","title":"S-8 — Tonix Pharmaceuticals Holding Corp. — 2026-07-01","url_slug":"/sec/cik-0001430306/s-8/0001493152-26-031574","accession_number":"0001493152-26-031574","importance":30},{"ts":"2026-06-30","kind":"sec.insider.j","reporter":"SAENGER BRADLEY","title":"Chief Financial Officer","shares":1453,"price_per_share":10.914,"usd_value":15858,"security_title":"Common Stock, $0.001 par value","importance":15.015858042},{"ts":"2026-06-29","kind":"sec.filing","form_type":"8-K","title":"8-K — Tonix Pharmaceuticals Holding Corp. — 2026-06-29","url_slug":"/sec/cik-0001430306/8-k/0001493152-26-030408","accession_number":"0001493152-26-030408","importance":35},{"ts":"2026-06-15","kind":"sec.filing","form_type":"4","title":"4 — Tonix Pharmaceuticals Holding Corp. — 2026-06-15","url_slug":"/sec/cik-0001430306/4/0001493152-26-028608","accession_number":"0001493152-26-028608","importance":30},{"ts":"2026-06-12","kind":"sec.insider.p","reporter":"Taylor Carolyn E.","title":"","shares":1415,"price_per_share":10.55,"usd_value":14928,"security_title":"Common Stock, $0.001 par value","importance":50.01492825},{"ts":"2026-06-09","kind":"sec.insider.p","reporter":"LEDERMAN SETH","title":"Chief Executive Officer","shares":5000,"price_per_share":11.79,"usd_value":58950,"security_title":"Common Stock, $0.001 par value","importance":50.05895},{"ts":"2026-06-09","kind":"sec.filing","form_type":"4","title":"4 — Tonix Pharmaceuticals Holding Corp. — 2026-06-09","url_slug":"/sec/cik-0001430306/4/0001493152-26-027985","accession_number":"0001493152-26-027985","importance":30},{"ts":"2026-06-09","kind":"sec.filing","form_type":"4","title":"4 — Tonix Pharmaceuticals Holding Corp. — 2026-06-09","url_slug":"/sec/cik-0001430306/4/0001493152-26-027986","accession_number":"0001493152-26-027986","importance":30},{"ts":"2026-06-08","kind":"sec.insider.p","reporter":"Stillwell Richard Newcomb","title":"","shares":5000,"price_per_share":11.65,"usd_value":58250,"security_title":"Common Stock, $0.001 par value","importance":50.05825},{"ts":"2026-06-08","kind":"sec.filing","form_type":"8-K","title":"8-K — Tonix Pharmaceuticals Holding Corp. — 2026-06-08","url_slug":"/sec/cik-0001430306/8-k/0001493152-26-027621","accession_number":"0001493152-26-027621","importance":35},{"ts":"2026-05-14","kind":"sec.filing","form_type":"4","title":"4 — Tonix Pharmaceuticals Holding Corp. — 2026-05-14","url_slug":"/sec/cik-0001430306/4/0001999371-26-010747","accession_number":"0001999371-26-010747","importance":30},{"ts":"2026-05-14","kind":"sec.filing","form_type":"4","title":"4 — Tonix Pharmaceuticals Holding Corp. — 2026-05-14","url_slug":"/sec/cik-0001430306/4/0001999371-26-010750","accession_number":"0001999371-26-010750","importance":30},{"ts":"2026-05-14","kind":"sec.filing","form_type":"4","title":"4 — Tonix Pharmaceuticals Holding Corp. — 2026-05-14","url_slug":"/sec/cik-0001430306/4/0001999371-26-010751","accession_number":"0001999371-26-010751","importance":30},{"ts":"2026-05-14","kind":"sec.filing","form_type":"4","title":"4 — Tonix Pharmaceuticals Holding Corp. — 2026-05-14","url_slug":"/sec/cik-0001430306/4/0001999371-26-010752","accession_number":"0001999371-26-010752","importance":30},{"ts":"2026-05-14","kind":"sec.filing","form_type":"4","title":"4 — Tonix Pharmaceuticals Holding Corp. — 2026-05-14","url_slug":"/sec/cik-0001430306/4/0001999371-26-010754","accession_number":"0001999371-26-010754","importance":30},{"ts":"2026-05-11","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Tonix Pharmaceuticals Holding Corp. — 2026-05-11","url_slug":"/sec/cik-0001430306/10-q/0001999371-26-010486","accession_number":"0001999371-26-010486","importance":45},{"ts":"2026-05-11","kind":"sec.filing","form_type":"8-K","title":"8-K — Tonix Pharmaceuticals Holding Corp. — 2026-05-11","url_slug":"/sec/cik-0001430306/8-k/0001999371-26-010487","accession_number":"0001999371-26-010487","importance":35}]}